Tennessee Senate Bill SB1722

Tennessee 2025-2026 Regular Session

• Introduced: 1/15/26

Caption

AN ACT to amend Tennessee Code Annotated, Title 56, Chapter 7, Part 23, relative to medical laboratories.

Impact

SB1722 is expected to substantially impact the regulation of medical laboratories by redefining the relationships between health insurers and medical service providers. The legislative changes will facilitate increased access to laboratory services for patients, allowing for a broader selection of laboratories without discrimination. This could theoretically lead to improved patient care by enabling individuals to choose laboratories closest to their needs or those that offer specialized services not covered by their main provider. However, while the bill supports fair competition among medical laboratories, it also places certain requirements on non-network labs to match in-network performance standards which could bring challenges for some providers.

Summary

Senate Bill 1722 (SB1722) proposes significant amendments to the Tennessee Code regarding medical laboratories. This bill mandates that health insurance issuers cannot deny licensed medical laboratories the right to participate as a provider under equal terms as other laboratories. Furthermore, it specifies that individuals covered by a health insurance policy can select any licensed medical laboratory as long as it meets the stipulated conditions of participation, thus promoting consumer choice in healthcare services. The bill also aims to set standards for reimbursement rates to non-network medical laboratories, ensuring they align with federal guidelines if the laboratory meets performance metrics akin to in-network establishments.

Sentiment

The sentiment regarding SB1722 appears to be cautiously optimistic within the health community. Supporters are likely to appreciate the emphasis on patient choice and more equitable treatment of medical laboratories. However, there may be reservations regarding the enforcement of performance metrics on non-network laboratories and whether this could inadvertently limit consumer choices if stricter standards lead to fewer participating providers. The discussions may reflect a dual concern for both patient rights and the operational capacity of medical service providers in a changing regulatory landscape.

Contention

One notable point of contention surrounding the bill involves how the reimbursement rates will be enforced for non-network providers. There may be debates about whether the performance metrics are too stringent, potentially sidelining smaller or less technologically advanced laboratories which may struggle to meet the same standards as larger, established facilities. Critics might argue that these requirements could inadvertently lead to reduced access to lab services in rural or underserved areas, counteracting some of the bill's intended benefits. Overall, while SB1722 aims to enhance healthcare options, it raises important questions about balance and practicality in implementation.